ClinicalTrials.Veeva

Menu

Gen2 Isthmus-Dependent Atrial Flutter Ablation Study

Abbott logo

Abbott

Status

Terminated

Conditions

Atrial Flutter

Treatments

Device: Cardiac Ablation (Gen2 Cardiac Ablation System)

Study type

Interventional

Funder types

Industry

Identifiers

Details and patient eligibility

About

Irrigated catheter for ablation of isthmus-dependent atrial flutter

Full description

This study intends to use an investigational irrigated catheter for ablation of isthmus-dependent atrial flutter

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Scheduled for ablation of isthmus-dependent atrial flutter

Exclusion criteria

  • Prior ablation of isthmus-dependent atrial flutter
  • Atypical or scar flutter
  • Significant heart disease
  • Intracardiac thrombus
  • Prior cardiac surgery (within 1 month)
  • Contraindication to heparin

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

30 participants in 1 patient group

(Gen2 Cardiac Ablation System)
Experimental group
Description:
Ablation of isthmus-dependent atrial flutter
Treatment:
Device: Cardiac Ablation (Gen2 Cardiac Ablation System)

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems